Kelsey Goune

Kelsey Goune has a background in stem cell biology and tissue regeneration. Currently completing her MS in Translational Research and Applied Medicine, she aims to integrate scientific rigor and entrepreneurship training to identify and scale companies commercializing transformative technologies that drive patient impact. She has gained experience in industry and academia at Vertex Pharmaceuticals and Harvard University’s Department of Stem Cell and Regenerative Biology. There, she led process development studies for a type 1 diabetes cell therapy and for muscular dystrophies, co-authoring research published in Nature Biotechnology. Her aspirations are driven by a commitment to supporting significant innovations in biotechnology and healthcare through strategic risk-taking.